Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Live birth rate per couple (all cycles)‐ clomiphene citrate or letrozole · participants with unexplained subfertility
IUI in a stimulated cycle probably leads to higher live birth rate per couple (all cycles)‐ clomiphene citrate or… compared with TI or expectant management (moderate certainty).
1 finding from 1 review
Live birth rate per couple · participants with unexplained subfertility
IUI in a stimulated cycle showed no clear difference in live birth rate per couple (all cycles)‐ clomiphene citrate or… compared with TI or expectant management (low certainty).
1 finding from 1 review
Pregnancy rate · participants with unexplained subfertility
IUI in a stimulated cycle probably leads to higher pregnancy rate per couple (all cycles)‐ clomiphene citrate or… compared with TI or expectant management (moderate certainty).
1 finding from 1 review
OHSS · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether antioestrogen changes clomiphene citrate plus tamoxifen versus clomiphene citrate ‐… compared with antioestrogen (very low certainty).
2 findings from 1 review
Clomiphene citrate plus ketoconazole versus clomiphene citrate · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clinical pregnancy · ovulation induction in polycystic ovarian syndrome
Antioestrogen plus medical adjunct showed no clear difference in clomiphene citrate plus bromocriptine versus clomiphene citrate ‐… compared with antioestrogen alone (low certainty).
1 finding from 1 review
Clomiphene citrate plus dexamethasone versus clomiphene citrate · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Miscarriage · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clomiphene citrate plus hCG versus clomiphene citrate alone · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clomiphene citrate plus hormone supplementation versus clomiphene citrate alone · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Live birth ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
The intervention may leads to lower live birth ‐ Clomiphene citrate 5 days versus clomiphene citrate 10… (low certainty).
1 finding from 1 review
Intervention not reported
Clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
The intervention may leads to lower clinical pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (low certainty).
1 finding from 1 review
Intervention not reported
Multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene citrate 10 days · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether the intervention changes multiple pregnancy ‐ Clomiphene citrate 5 days versus clomiphene… (very low certainty).
1 finding from 1 review
Intervention not reported
Miscarriage rate ‐ Early versus late clomiphene citrate · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether the intervention changes miscarriage rate ‐ Early versus late clomiphene citrate (very low certainty).
1 finding from 1 review
Intervention not reported
Clinical pregnancy ‐ Early versus late clomiphene citrate · ovulation induction in polycystic ovarian syndrome
The intervention may leads to higher clinical pregnancy ‐ Early versus late clomiphene citrate (low certainty).
1 finding from 1 review
Live birth rate · ovulation induction in polycystic ovarian syndrome
Antioestrogen showed no clear difference in clomiphene citrate versus tamoxifen ‐ Live birth rate compared with antioestrogen (low certainty).
1 finding from 1 review
Miscarriage · ovulation induction in polycystic ovarian syndrome
Antioestrogen showed no clear difference in clomiphene citrate versus tamoxifen ‐ Miscarriage rate compared with antioestrogen (low certainty).
1 finding from 1 review
Multiple pregnancy · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether antioestrogen changes clomiphene citrate versus tamoxifen ‐ Multiple pregnancy compared with antioestrogen (very low certainty).
1 finding from 1 review